[
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell doesn't recognize foreign antigens after mutation, it'll be targeted by the host's immune system, causing rejection.",
    "rollout": " For example, if a T-cell doesn't recognize foreign antigens after mutation, it'll be targeted by the host's immune system, causing rejection. So the key point here is that mutation and recombination cause T-cells to fail in recognizing foreign materials, leading to rejection. Therefore, the best answer should be option B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell doesn't recognize foreign antigens after mutation, it'll be targeted by the host's immune system, causing rejection. So the key point here is that mutation and recombination cause T-cells to fail in recognizing foreign materials, leading to rejection. Therefore, the best answer should be option B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell doesn't recognize an antigen, it won't attack the foreign material, causing rejection.",
    "rollout": " For example, if a T-cell doesn't recognize an antigen, it won't attack the foreign material, causing rejection. So these options all tie into why mutation and recombination cause rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell doesn't recognize an antigen, it won't attack the foreign material, causing rejection. So these options all tie into why mutation and recombination cause rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell can't distinguish itself from others, it might not properly target the foreign antigen, causing rejection.",
    "rollout": " For example, if a T-cell can't distinguish itself from others, it might not properly target the foreign antigen, causing rejection. So these options are supporting the idea that mutation and recombination are involved in T-cell function, thus affecting graft rejection. Therefore, the best answer should be B because it directly links mutation and recombination to T-cell maturation and recognition.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell can't distinguish itself from others, it might not properly target the foreign antigen, causing rejection. So these options are supporting the idea that mutation and recombination are involved in T-cell function, thus affecting graft rejection. Therefore, the best answer should be B because it directly links mutation and recombination to T-cell maturation and recognition.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell doesn't recognize an antigen correctly due to mutation, it will reject the graft.",
    "rollout": " For example, if a T-cell doesn't recognize an antigen correctly due to mutation, it will reject the graft. So these options support the idea that mutation and recombination cause issues during T-cell maturation, leading to rejection. Therefore, the best answer would be option B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell doesn't recognize an antigen correctly due to mutation, it will reject the graft. So these options support the idea that mutation and recombination cause issues during T-cell maturation, leading to rejection. Therefore, the best answer would be option B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So I think B is the best answer.",
    "rollout": " So I think B is the best answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So I think B is the best answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells can't recognize foreign antigens, they won't attack the graft, causing rejection.",
    "rollout": " For example, if T-cells can't recognize foreign antigens, they won't attack the graft, causing rejection. So B seems to directly address this mechanism.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells can't recognize foreign antigens, they won't attack the graft, causing rejection. So B seems to directly address this mechanism.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells aren't properly recognized, they'll attack the foreign material instead of helping the body find an alternative way.",
    "rollout": " For example, if T-cells aren't properly recognized, they'll attack the foreign material instead of helping the body find an alternative way. So putting it together, option B fits best because it directly links mutation and recombination during T-cell maturation to cells recognizing foreign antigens, causing rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells aren't properly recognized, they'll attack the foreign material instead of helping the body find an alternative way. So putting it together, option B fits best because it directly links mutation and recombination during T-cell maturation to cells recognizing foreign antigens, causing rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells aren't good at recognizing antigens, they won't target the foreign material, causing rejection.",
    "rollout": " For example, if T-cells aren't good at recognizing antigens, they won't target the foreign material, causing rejection. So the key here is that mutation and recombination enhance T-cell functionality, particularly their ability to recognize foreign antigens, thus contributing to rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells aren't good at recognizing antigens, they won't target the foreign material, causing rejection. So the key here is that mutation and recombination enhance T-cell functionality, particularly their ability to recognize foreign antigens, thus contributing to rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell can't distinguish self and non-self, it might not attack the foreign material as well, causing rejection.",
    "rollout": " For example, if a T-cell can't distinguish self and non-self, it might not attack the foreign material as well, causing rejection. So B and I seem related. Wait, the question asks how mutation and recombination contribute to rejection. So B specifically mentions T-cell maturation in the thymus resulting in cells that recognize foreign antigens, which directly causes rejection. The other options either talk about other immune mechanisms or processes but aren't directly contributing to rejection. So the best answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell can't distinguish self and non-self, it might not attack the foreign material as well, causing rejection. So B and I seem related. Wait, the question asks how mutation and recombination contribute to rejection. So B specifically mentions T-cell maturation in the thymus resulting in cells that recognize foreign antigens, which directly causes rejection. The other options either talk about other immune mechanisms or processes but aren't directly contributing to rejection. So the best answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So B and possibly others.",
    "rollout": " So B and possibly others. Wait, the question asks how mutation and recombination contribute specifically to tissue rejection. B mentions that mutation and recombination cause T-cells to recognize foreign antigens, which fits. The other options either talk about repair (D) or something else unrelated. So the best answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So B and possibly others. Wait, the question asks how mutation and recombination contribute specifically to tissue rejection. B mentions that mutation and recombination cause T-cells to recognize foreign antigens, which fits. The other options either talk about repair (D) or something else unrelated. So the best answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells aren't recognizing foreign antigens well due to mutations, they'll attack the foreign material, causing rejection.",
    "rollout": " For example, if T-cells aren't recognizing foreign antigens well due to mutations, they'll attack the foreign material, causing rejection. So these options are supporting the idea that mutation leads to recombination that results in T-cells rejecting the foreign material. Therefore, the answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells aren't recognizing foreign antigens well due to mutations, they'll attack the foreign material, causing rejection. So these options are supporting the idea that mutation leads to recombination that results in T-cells rejecting the foreign material. Therefore, the answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells aren't recognized well, they might not attack the foreign tissue, causing rejection.",
    "rollout": " For example, if T-cells aren't recognized well, they might not attack the foreign tissue, causing rejection. So combining mutation and recombination would enhance this process, making the immune system less effective against the foreign antigen, hence rejection. Therefore, the best answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells aren't recognized well, they might not attack the foreign tissue, causing rejection. So combining mutation and recombination would enhance this process, making the immune system less effective against the foreign antigen, hence rejection. Therefore, the best answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell can't recognize foreign antigens, it won't attack the graft, causing rejection.",
    "rollout": " For example, if a T-cell can't recognize foreign antigens, it won't attack the graft, causing rejection. So putting it together, option B seems to directly address how mutation and recombination during T-cell maturation in the thymus cause T-cells to recognize foreign antigens, thus contributing to rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell can't recognize foreign antigens, it won't attack the graft, causing rejection. So putting it together, option B seems to directly address how mutation and recombination during T-cell maturation in the thymus cause T-cells to recognize foreign antigens, thus contributing to rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells aren't properly recognizing foreign antigens, they won't attack the graft, causing rejection.",
    "rollout": " For example, if T-cells aren't properly recognizing foreign antigens, they won't attack the graft, causing rejection. So B seems solid. Other options either ignore the effect on T-cells or suggest incorrect mechanisms. Therefore, B should be the answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells aren't properly recognizing foreign antigens, they won't attack the graft, causing rejection. So B seems solid. Other options either ignore the effect on T-cells or suggest incorrect mechanisms. Therefore, B should be the answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So B seems to fit best because it directly links mutation and recombination to T-cell maturation and aiding in the rejection.",
    "rollout": " So B seems to fit best because it directly links mutation and recombination to T-cell maturation and aiding in the rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So B seems to fit best because it directly links mutation and recombination to T-cell maturation and aiding in the rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So putting it together, B seems to directly address how mutation affects T-cell maturation, which then leads to cell recognition and rejection.",
    "rollout": " So putting it together, B seems to directly address how mutation affects T-cell maturation, which then leads to cell recognition and rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So putting it together, B seems to directly address how mutation affects T-cell maturation, which then leads to cell recognition and rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell has mutations, it might not correctly recognize foreign antigens, causing it to be targeted instead of being sent elsewhere.",
    "rollout": " For example, if a T-cell has mutations, it might not correctly recognize foreign antigens, causing it to be targeted instead of being sent elsewhere. So, these options all tie into why mutation and recombination would cause rejection. The key point here is that without proper recognition, the body rejects the graft. Therefore, option B seems to best explain how mutation and recombination contribute to tissue graft rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell has mutations, it might not correctly recognize foreign antigens, causing it to be targeted instead of being sent elsewhere. So, these options all tie into why mutation and recombination would cause rejection. The key point here is that without proper recognition, the body rejects the graft. Therefore, option B seems to best explain how mutation and recombination contribute to tissue graft rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells aren't recognizing foreign antigens properly due to mutations, they won't attack the foreign material, causing rejection.",
    "rollout": " For example, if T-cells aren't recognizing foreign antigens properly due to mutations, they won't attack the foreign material, causing rejection. So B seems to capture that mechanism. I'm pretty confident now that B is the answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells aren't recognizing foreign antigens properly due to mutations, they won't attack the foreign material, causing rejection. So B seems to capture that mechanism. I'm pretty confident now that B is the answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells can't distinguish between self and non-self, they'll attack the foreign material instead.",
    "rollout": " For example, if T-cells can't distinguish between self and non-self, they'll attack the foreign material instead. So B seems the best fit.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells can't distinguish between self and non-self, they'll attack the foreign material instead. So B seems the best fit.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell isn't recognizing an antigen correctly, it won't target it, causing rejection.",
    "rollout": " For example, if a T-cell isn't recognizing an antigen correctly, it won't target it, causing rejection. So these options are related but not directly explaining how mutation contributes specifically to recombination aiding in rejection. The main point is that during T-cell maturation, mutations allow T-cells to recognize foreign antigens, leading to rejection. Therefore, option B fits best.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell isn't recognizing an antigen correctly, it won't target it, causing rejection. So these options are related but not directly explaining how mutation contributes specifically to recombination aiding in rejection. The main point is that during T-cell maturation, mutations allow T-cells to recognize foreign antigens, leading to rejection. Therefore, option B fits best.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells can't recognize antigens, they won't target the foreign material, causing rejection.",
    "rollout": " For example, if T-cells can't recognize antigens, they won't target the foreign material, causing rejection. So looking back at the options, B seems to directly address T-cell maturation and their ability to recognize foreign antigens, which contributes to rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells can't recognize antigens, they won't target the foreign material, causing rejection. So looking back at the options, B seems to directly address T-cell maturation and their ability to recognize foreign antigens, which contributes to rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell can't distinguish between self and non-self, it won't react to foreign antigens, thus rejecting the graft.",
    "rollout": " For example, if a T-cell can't distinguish between self and non-self, it won't react to foreign antigens, thus rejecting the graft. So B seems to tie everything together.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell can't distinguish between self and non-self, it won't react to foreign antigens, thus rejecting the graft. So B seems to tie everything together.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So putting it together, B seems to correctly state that mutation and recombination during T-cell maturation result in T-cells that recognize foreign antigens, causing rejection.",
    "rollout": " So putting it together, B seems to correctly state that mutation and recombination during T-cell maturation result in T-cells that recognize foreign antigens, causing rejection. The other options either go into details like repair mechanisms or incorrect biological roles of mutations.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So putting it together, B seems to correctly state that mutation and recombination during T-cell maturation result in T-cells that recognize foreign antigens, causing rejection. The other options either go into details like repair mechanisms or incorrect biological roles of mutations.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells can't recognize antigens, they'll attack the foreign material, causing rejection.",
    "rollout": " For example, if T-cells can't recognize antigens, they'll attack the foreign material, causing rejection. So looking back, B seems to directly address T-cell maturation and their ability to recognize foreign antigens, which aligns with tissue rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells can't recognize antigens, they'll attack the foreign material, causing rejection. So looking back, B seems to directly address T-cell maturation and their ability to recognize foreign antigens, which aligns with tissue rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So B and I seem important here.",
    "rollout": " So B and I seem important here. But since the question asks for a single answer, I need to choose the most direct one. The key is that mutation and recombination improve T-cell function, allowing them to recognize foreign antigens, which leads to rejection. Therefore, option B fits best.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So B and I seem important here. But since the question asks for a single answer, I need to choose the most direct one. The key is that mutation and recombination improve T-cell function, allowing them to recognize foreign antigens, which leads to rejection. Therefore, option B fits best.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell doesn't recognize an antigen correctly after mutation, it won't bind to it, causing the graft to be rejected.",
    "rollout": " For example, if a T-cell doesn't recognize an antigen correctly after mutation, it won't bind to it, causing the graft to be rejected. So looking back, B seems to directly link mutation during T-cell maturation to cells recognizing foreign antigens, thus contributing to rejection. The other options either discuss unrelated processes or incorrect roles of mutation and recombination.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell doesn't recognize an antigen correctly after mutation, it won't bind to it, causing the graft to be rejected. So looking back, B seems to directly link mutation during T-cell maturation to cells recognizing foreign antigens, thus contributing to rejection. The other options either discuss unrelated processes or incorrect roles of mutation and recombination.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells aren't able to distinguish self from non-self (H), they might reject the graft.",
    "rollout": " For example, if T-cells aren't able to distinguish self from non-self (H), they might reject the graft. Similarly, if they're identical (I), that reduces variability and helps the immune system focus better. Reducing the immune response (F) also contributes to rejection since the body has less exposure to foreign threats. Increasing tolerance (G) would mean the body accepts the graft more easily. So putting it together, option B fits best because it directly links mutation during T-cell maturation to cells recognizing foreign antigens, aiding in rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells aren't able to distinguish self from non-self (H), they might reject the graft. Similarly, if they're identical (I), that reduces variability and helps the immune system focus better. Reducing the immune response (F) also contributes to rejection since the body has less exposure to foreign threats. Increasing tolerance (G) would mean the body accepts the graft more easily. So putting it together, option B fits best because it directly links mutation during T-cell maturation to cells recognizing foreign antigens, aiding in rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells can't recognize foreign antigens, they'll be targeted and rejected.",
    "rollout": " For example, if T-cells can't recognize foreign antigens, they'll be targeted and rejected. So these options collectively point towards B being the correct answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells can't recognize foreign antigens, they'll be targeted and rejected. So these options collectively point towards B being the correct answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "- Option H suggests generating T-cells that can't distinguish self from non-self.",
    "rollout": " - Option H suggests generating T-cells that can't distinguish self from non-self. That would definitely lead to rejection since they'd be confused about what's foreign. - Option J says T-cells delete each other if they can respond to foreign antigens. Again, that leads to confusion, causing rejection. So putting it all together, the key point is that mutation in T-cells' receptors helps them recognize foreign antigens, leading to rejection. Therefore, the answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. - Option H suggests generating T-cells that can't distinguish self from non-self. That would definitely lead to rejection since they'd be confused about what's foreign. - Option J says T-cells delete each other if they can respond to foreign antigens. Again, that leads to confusion, causing rejection. So putting it all together, the key point is that mutation in T-cells' receptors helps them recognize foreign antigens, leading to rejection. Therefore, the answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell doesn't recognize an antigen correctly due to mutation, it'll be targeted by the body's natural immune response rather than attacking the foreign material, thus rejecting the graft.",
    "rollout": " For example, if a T-cell doesn't recognize an antigen correctly due to mutation, it'll be targeted by the body's natural immune response rather than attacking the foreign material, thus rejecting the graft. \n\nSo putting it together, option B fits best because it directly links mutation and recombination during T-cell maturation (in the thymus) to cells that recognize foreign antigens, causing tissue rejection. Other options either discuss unrelated processes or inaccurately describe the effects of mutation/recombination on immune response.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell doesn't recognize an antigen correctly due to mutation, it'll be targeted by the body's natural immune response rather than attacking the foreign material, thus rejecting the graft. \n\nSo putting it together, option B fits best because it directly links mutation and recombination during T-cell maturation (in the thymus) to cells that recognize foreign antigens, causing tissue rejection. Other options either discuss unrelated processes or inaccurately describe the effects of mutation/recombination on immune response.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells have mutations that impair antigen recognition, they won't properly target the foreign material, causing rejection.",
    "rollout": " For example, if T-cells have mutations that impair antigen recognition, they won't properly target the foreign material, causing rejection. So putting it together, option B seems to directly address how mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells have mutations that impair antigen recognition, they won't properly target the foreign material, causing rejection. So putting it together, option B seems to directly address how mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell can't recognize an antigen, it won't attack the foreign material, causing rejection.",
    "rollout": " For example, if a T-cell can't recognize an antigen, it won't attack the foreign material, causing rejection. So looking back, option B aligns with these mechanisms.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell can't recognize an antigen, it won't attack the foreign material, causing rejection. So looking back, option B aligns with these mechanisms.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell can't recognize foreign antigens, it won't attack the graft, causing rejection.",
    "rollout": " For example, if a T-cell can't recognize foreign antigens, it won't attack the graft, causing rejection. So B seems to fit well.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell can't recognize foreign antigens, it won't attack the graft, causing rejection. So B seems to fit well.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So putting it together, B seems to be the best answer.",
    "rollout": " So putting it together, B seems to be the best answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So putting it together, B seems to be the best answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell can't recognize foreign antigens, it won't target the graft properly, causing rejection.",
    "rollout": " For example, if a T-cell can't recognize foreign antigens, it won't target the graft properly, causing rejection. So these options seem related but aren't the main cause. - Option B specifically mentions T-cell maturation, which is crucial because once T-cells mature, they have higher specificity. So focusing on B would be key. The rest are supporting facts rather than the cause. Therefore, the best answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell can't recognize foreign antigens, it won't target the graft properly, causing rejection. So these options seem related but aren't the main cause. - Option B specifically mentions T-cell maturation, which is crucial because once T-cells mature, they have higher specificity. So focusing on B would be key. The rest are supporting facts rather than the cause. Therefore, the best answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell mutates and can't recognize foreign antigens, it would be targeted away, causing rejection.",
    "rollout": " For example, if a T-cell mutates and can't recognize foreign antigens, it would be targeted away, causing rejection. So B seems to tie into the main mechanism.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell mutates and can't recognize foreign antigens, it would be targeted away, causing rejection. So B seems to tie into the main mechanism.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if mutations cause T-cells to not recognize foreign antigens, they would naturally be targeted, causing rejection.",
    "rollout": " For example, if mutations cause T-cells to not recognize foreign antigens, they would naturally be targeted, causing rejection. So B is saying that mutation during T-cell maturation results in T-cells that recognize foreign antigens. That fits because T-cells are critical in fighting foreign invaders. Therefore, B seems to directly address how mutation affects T-cell function in rejecting grafts.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if mutations cause T-cells to not recognize foreign antigens, they would naturally be targeted, causing rejection. So B is saying that mutation during T-cell maturation results in T-cells that recognize foreign antigens. That fits because T-cells are critical in fighting foreign invaders. Therefore, B seems to directly address how mutation affects T-cell function in rejecting grafts.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if mutations cause T-cells to not recognize foreign antigens, they'd be rejected.",
    "rollout": " For example, if mutations cause T-cells to not recognize foreign antigens, they'd be rejected. So I think option B is the key here.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if mutations cause T-cells to not recognize foreign antigens, they'd be rejected. So I think option B is the key here.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So the key here is how mutations and recombination enhance T-cell function, causing them to reject foreign antigens.",
    "rollout": " So the key here is how mutations and recombination enhance T-cell function, causing them to reject foreign antigens. Therefore, the best answer should be option B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So the key here is how mutations and recombination enhance T-cell function, causing them to reject foreign antigens. Therefore, the best answer should be option B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So putting it together, the main point is that during T-cell maturation, mutations cause T-cells to be more sensitive to foreign antigens, causing them to reject the graft.",
    "rollout": " So putting it together, the main point is that during T-cell maturation, mutations cause T-cells to be more sensitive to foreign antigens, causing them to reject the graft.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So putting it together, the main point is that during T-cell maturation, mutations cause T-cells to be more sensitive to foreign antigens, causing them to reject the graft.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell can't distinguish itself from the antigen, it won't react properly.",
    "rollout": " For example, if a T-cell can't distinguish itself from the antigen, it won't react properly. So B fits best as it directly ties mutation and recombination to T-cell maturation and aiding in rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell can't distinguish itself from the antigen, it won't react properly. So B fits best as it directly ties mutation and recombination to T-cell maturation and aiding in rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells can't recognize foreign antigens (F), they won't attack the graft, causing rejection.",
    "rollout": " For example, if T-cells can't recognize foreign antigens (F), they won't attack the graft, causing rejection. Similarly, if they have identical receptors (I), even if they're supposed to recognize antigens, they'll do so the same way, possibly increasing the risk. So B and J seem important here. Wait, but the question asks how mutation and recombination contribute specifically to tissue rejection. So focusing on mechanisms where these factors directly affect T-cell function and antigen recognition would be key. Between B and J, both touch upon T-cell function. The best answer would be B because it directly ties mutation and recombination to T-cell maturation and their ability to recognize foreign antigens, thus leading to graft rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells can't recognize foreign antigens (F), they won't attack the graft, causing rejection. Similarly, if they have identical receptors (I), even if they're supposed to recognize antigens, they'll do so the same way, possibly increasing the risk. So B and J seem important here. Wait, but the question asks how mutation and recombination contribute specifically to tissue rejection. So focusing on mechanisms where these factors directly affect T-cell function and antigen recognition would be key. Between B and J, both touch upon T-cell function. The best answer would be B because it directly ties mutation and recombination to T-cell maturation and their ability to recognize foreign antigens, thus leading to graft rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells can't recognize foreign antigens, they won't destroy the graft, causing rejection.",
    "rollout": " For example, if T-cells can't recognize foreign antigens, they won't destroy the graft, causing rejection. So B seems best because it directly ties mutation and recombination to T-cell activity during maturation, which is crucial for rejecting the graft.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells can't recognize foreign antigens, they won't destroy the graft, causing rejection. So B seems best because it directly ties mutation and recombination to T-cell activity during maturation, which is crucial for rejecting the graft.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells aren't able to recognize foreign antigens well, they won't take up the foreign material, causing rejection.",
    "rollout": " For example, if T-cells aren't able to recognize foreign antigens well, they won't take up the foreign material, causing rejection. So putting it together, option B seems to directly address how mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells aren't able to recognize foreign antigens well, they won't take up the foreign material, causing rejection. So putting it together, option B seems to directly address how mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells aren't properly recognized, they won't find the foreign antigen, causing rejection.",
    "rollout": " For example, if T-cells aren't properly recognized, they won't find the foreign antigen, causing rejection. So putting it together, option B seems to address how mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, thus contributing to rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells aren't properly recognized, they won't find the foreign antigen, causing rejection. So putting it together, option B seems to address how mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, thus contributing to rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So, putting it together, option B seems to directly link mutation during T-cell maturation to T-cell mediated rejection.",
    "rollout": " So, putting it together, option B seems to directly link mutation during T-cell maturation to T-cell mediated rejection. The rest either talk about unrelated mechanisms or incorrect effects. Therefore, B is the best answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So, putting it together, option B seems to directly link mutation during T-cell maturation to T-cell mediated rejection. The rest either talk about unrelated mechanisms or incorrect effects. Therefore, B is the best answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells aren't recognizing antigens well after mutation, they'll target the foreign material instead of attacking the healthy cell.",
    "rollout": " For example, if T-cells aren't recognizing antigens well after mutation, they'll target the foreign material instead of attacking the healthy cell. That fits with the concept of T-cell mediated rejection. So putting it together, option B seems to cover both mutation and recombination during T-cell maturation resulting in cells that recognize foreign antigens, thus contributing to tissue rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells aren't recognizing antigens well after mutation, they'll target the foreign material instead of attacking the healthy cell. That fits with the concept of T-cell mediated rejection. So putting it together, option B seems to cover both mutation and recombination during T-cell maturation resulting in cells that recognize foreign antigens, thus contributing to tissue rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells can't recognize foreign antigens due to mutation, they won't target those materials, causing rejection.",
    "rollout": " For example, if T-cells can't recognize foreign antigens due to mutation, they won't target those materials, causing rejection. So among these, B seems to directly address the process described. The other options either talk about unrelated processes or incorrect effects. Therefore, the answer should be option B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells can't recognize foreign antigens due to mutation, they won't target those materials, causing rejection. So among these, B seems to directly address the process described. The other options either talk about unrelated processes or incorrect effects. Therefore, the answer should be option B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So putting it together, option B seems to directly address how mutation and recombination cause T-cells to miss foreign antigens, leading to rejection.",
    "rollout": " So putting it together, option B seems to directly address how mutation and recombination cause T-cells to miss foreign antigens, leading to rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So putting it together, option B seems to directly address how mutation and recombination cause T-cells to miss foreign antigens, leading to rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells can't recognize foreign antigens, they won't target the graft properly, causing rejection.",
    "rollout": " For example, if T-cells can't recognize foreign antigens, they won't target the graft properly, causing rejection. So B seems to fit best.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells can't recognize foreign antigens, they won't target the graft properly, causing rejection. So B seems to fit best.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells can't recognize foreign antigens, they won't help in rejecting the graft.",
    "rollout": " For example, if T-cells can't recognize foreign antigens, they won't help in rejecting the graft. So these options are related but focus on the mechanisms rather than just the outcome. However, since the question asks how mutation and recombination contribute specifically to rejection, focusing on the mechanism would be better. Option B directly links mutation during T-cell maturation to cells recognizing foreign antigens, which contributes to rejection. The other options either talk about the broader immune response or repair processes, which are important but not specific to the cause of rejection. Therefore, the best answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells can't recognize foreign antigens, they won't help in rejecting the graft. So these options are related but focus on the mechanisms rather than just the outcome. However, since the question asks how mutation and recombination contribute specifically to rejection, focusing on the mechanism would be better. Option B directly links mutation during T-cell maturation to cells recognizing foreign antigens, which contributes to rejection. The other options either talk about the broader immune response or repair processes, which are important but not specific to the cause of rejection. Therefore, the best answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So B seems to directly address the process causing rejection through T-cell activity.",
    "rollout": " So B seems to directly address the process causing rejection through T-cell activity.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So B seems to directly address the process causing rejection through T-cell activity.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So the key point here is that mutation allows T-cells to recognize foreign antigens, causing them to be rejected.",
    "rollout": " So the key point here is that mutation allows T-cells to recognize foreign antigens, causing them to be rejected.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So the key point here is that mutation allows T-cells to recognize foreign antigens, causing them to be rejected.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So the main point here is whether mutations enhance or impair T-cell recognition.",
    "rollout": " So the main point here is whether mutations enhance or impair T-cell recognition. Since the question is about contribution to rejection, I think B is the best answer because it directly links mutation during T-cell maturation to cells recognizing foreign antigens, aiding in rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So the main point here is whether mutations enhance or impair T-cell recognition. Since the question is about contribution to rejection, I think B is the best answer because it directly links mutation during T-cell maturation to cells recognizing foreign antigens, aiding in rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So I think B is the best answer because it directly ties mutation and recombination to T-cell activity causing rejection.",
    "rollout": " So I think B is the best answer because it directly ties mutation and recombination to T-cell activity causing rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So I think B is the best answer because it directly ties mutation and recombination to T-cell activity causing rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So B seems the best answer because it directly links mutation during T-cell maturation to rejecting the graft through foreign recognition.",
    "rollout": " So B seems the best answer because it directly links mutation during T-cell maturation to rejecting the graft through foreign recognition.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So B seems the best answer because it directly links mutation during T-cell maturation to rejecting the graft through foreign recognition.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells can't recognize foreign antigens, they won't attack the graft.",
    "rollout": " For example, if T-cells can't recognize foreign antigens, they won't attack the graft. So combining mutation and recombination would enhance this effect. Therefore, option B seems to directly address how mutations during T-cell maturation help in rejecting the graft.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells can't recognize foreign antigens, they won't attack the graft. So combining mutation and recombination would enhance this effect. Therefore, option B seems to directly address how mutations during T-cell maturation help in rejecting the graft.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell can't recognize an antigen due to mutation, it won't attack the foreign material, leading to rejection.",
    "rollout": " For example, if a T-cell can't recognize an antigen due to mutation, it won't attack the foreign material, leading to rejection. So option B fits best as it directly links mutation during T-cell maturation to cell recognition and rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell can't recognize an antigen due to mutation, it won't attack the foreign material, leading to rejection. So option B fits best as it directly links mutation during T-cell maturation to cell recognition and rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell can't recognize an antigen due to mutation, it'll be targeted by the body instead of rejecting the graft.",
    "rollout": " For example, if a T-cell can't recognize an antigen due to mutation, it'll be targeted by the body instead of rejecting the graft. So, B seems to capture that scenario. The rest of the options either talk about unrelated mechanisms or incorrect roles of mutation and recombination. Therefore, the best answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell can't recognize an antigen due to mutation, it'll be targeted by the body instead of rejecting the graft. So, B seems to capture that scenario. The rest of the options either talk about unrelated mechanisms or incorrect roles of mutation and recombination. Therefore, the best answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell can't distinguish self from non-self, it would be more likely to accept foreign antigens, increasing rejection.",
    "rollout": " For example, if a T-cell can't distinguish self from non-self, it would be more likely to accept foreign antigens, increasing rejection. So putting it together, mutation and recombination enhance T-cell function, which leads to tissue graft rejection. Therefore, option B seems to correctly describe this mechanism.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell can't distinguish self from non-self, it would be more likely to accept foreign antigens, increasing rejection. So putting it together, mutation and recombination enhance T-cell function, which leads to tissue graft rejection. Therefore, option B seems to correctly describe this mechanism.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells can't recognize foreign antigens, they won't target them, causing rejection.",
    "rollout": " For example, if T-cells can't recognize foreign antigens, they won't target them, causing rejection. So these options are supporting the idea that mutation and recombination are key factors in T-cell-mediated rejection. Therefore, the best answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells can't recognize foreign antigens, they won't target them, causing rejection. So these options are supporting the idea that mutation and recombination are key factors in T-cell-mediated rejection. Therefore, the best answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So B seems the best fit because it directly links mutation and recombination to T-cell activity during maturation, which is crucial for rejecting the graft.",
    "rollout": " So B seems the best fit because it directly links mutation and recombination to T-cell activity during maturation, which is crucial for rejecting the graft.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So B seems the best fit because it directly links mutation and recombination to T-cell activity during maturation, which is crucial for rejecting the graft.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So B seems to be the best answer because it directly links mutation and recombination to T-cell activity and graft rejection.",
    "rollout": " So B seems to be the best answer because it directly links mutation and recombination to T-cell activity and graft rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So B seems to be the best answer because it directly links mutation and recombination to T-cell activity and graft rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So I need to pick the option that directly connects mutation and recombination to T-cell activity causing rejection.",
    "rollout": " So I need to pick the option that directly connects mutation and recombination to T-cell activity causing rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So I need to pick the option that directly connects mutation and recombination to T-cell activity causing rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell can't distinguish self from non-self, it would mistakenly attack the foreign material, causing rejection.",
    "rollout": " For example, if a T-cell can't distinguish self from non-self, it would mistakenly attack the foreign material, causing rejection. So options B and others are more directly related to the mechanism of rejection. Therefore, B seems to be the best answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell can't distinguish self from non-self, it would mistakenly attack the foreign material, causing rejection. So options B and others are more directly related to the mechanism of rejection. Therefore, B seems to be the best answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells aren't able to recognize foreign antigens, they won't target them, causing rejection.",
    "rollout": " For example, if T-cells aren't able to recognize foreign antigens, they won't target them, causing rejection. So these options are supporting the idea that mutation and recombination cause issues with T-cell function, hence rejection. Therefore, the best answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells aren't able to recognize foreign antigens, they won't target them, causing rejection. So these options are supporting the idea that mutation and recombination cause issues with T-cell function, hence rejection. Therefore, the best answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "- Option B specifically mentions during T-cell maturation in the thymus, which aligns with how the immune system operates after T-cell development.",
    "rollout": " - Option B specifically mentions during T-cell maturation in the thymus, which aligns with how the immune system operates after T-cell development. So B fits better than others. The other options either don't connect mutation-recombination directly to T-cell-mediated rejection or describe processes unrelated to immune system function.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. - Option B specifically mentions during T-cell maturation in the thymus, which aligns with how the immune system operates after T-cell development. So B fits better than others. The other options either don't connect mutation-recombination directly to T-cell-mediated rejection or describe processes unrelated to immune system function.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So B seems to be the best answer because it directly ties mutation and recombination to T-cell maturation and antigen recognition, which are key factors in graft rejection.",
    "rollout": " So B seems to be the best answer because it directly ties mutation and recombination to T-cell maturation and antigen recognition, which are key factors in graft rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So B seems to be the best answer because it directly ties mutation and recombination to T-cell maturation and antigen recognition, which are key factors in graft rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell doesn't recognize foreign antigens well due to mutation, it will be targeted by the immune system, leading to rejection of the graft.",
    "rollout": " For example, if a T-cell doesn't recognize foreign antigens well due to mutation, it will be targeted by the immune system, leading to rejection of the graft. So putting it together, the key point is that mutation and recombination enhance T-cell function, causing them to reject the foreign material and thus rejecting the graft.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell doesn't recognize foreign antigens well due to mutation, it will be targeted by the immune system, leading to rejection of the graft. So putting it together, the key point is that mutation and recombination enhance T-cell function, causing them to reject the foreign material and thus rejecting the graft.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell can't recognize foreign antigens, it won't attack the graft, causing rejection.",
    "rollout": " For example, if a T-cell can't recognize foreign antigens, it won't attack the graft, causing rejection. So options B, C, D, E, F, G, H, I, J, K? Wait, no, let's look again. The main point is about T-cell maturation leading to cells that recognize foreign antigens. So option B is about T-cell maturation resulting in cells that recognize foreign antigens, contributing to rejection. That fits well. Other options either talk about repair, identical receptors, etc., but those aren't directly addressing the mechanism of why T-cells would be recognized as foreign. So the answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell can't recognize foreign antigens, it won't attack the graft, causing rejection. So options B, C, D, E, F, G, H, I, J, K? Wait, no, let's look again. The main point is about T-cell maturation leading to cells that recognize foreign antigens. So option B is about T-cell maturation resulting in cells that recognize foreign antigens, contributing to rejection. That fits well. Other options either talk about repair, identical receptors, etc., but those aren't directly addressing the mechanism of why T-cells would be recognized as foreign. So the answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells can't recognize foreign antigens, they won't target them properly, causing rejection.",
    "rollout": " For example, if T-cells can't recognize foreign antigens, they won't target them properly, causing rejection. So these options are related but focus on specific mechanisms rather than just saying they happen. However, the key point is that mutation and recombination enhance T-cell function, which leads to rejection. Therefore, the most accurate answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells can't recognize foreign antigens, they won't target them properly, causing rejection. So these options are related but focus on specific mechanisms rather than just saying they happen. However, the key point is that mutation and recombination enhance T-cell function, which leads to rejection. Therefore, the most accurate answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So B seems to directly address the process of T-cell maturation resulting in cells that recognize foreign antigens, thus contributing to rejection.",
    "rollout": " So B seems to directly address the process of T-cell maturation resulting in cells that recognize foreign antigens, thus contributing to rejection. The other options either talk about unrelated mechanisms or incorrect roles of mutation.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So B seems to directly address the process of T-cell maturation resulting in cells that recognize foreign antigens, thus contributing to rejection. The other options either talk about unrelated mechanisms or incorrect roles of mutation.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells can't recognize foreign antigens due to mutations, they won't attack the graft, causing rejection.",
    "rollout": " For example, if T-cells can't recognize foreign antigens due to mutations, they won't attack the graft, causing rejection. So putting it together, option B fits best.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells can't recognize foreign antigens due to mutations, they won't attack the graft, causing rejection. So putting it together, option B fits best.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So B seems to fit best because it directly links mutation during T-cell maturation to T-cell-mediated rejection.",
    "rollout": " So B seems to fit best because it directly links mutation during T-cell maturation to T-cell-mediated rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So B seems to fit best because it directly links mutation during T-cell maturation to T-cell-mediated rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "- Option B specifically mentions T-cell maturation in the thymus resulting in cells that recognize foreign antigens, which directly ties into the problem.",
    "rollout": " - Option B specifically mentions T-cell maturation in the thymus resulting in cells that recognize foreign antigens, which directly ties into the problem.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. - Option B specifically mentions T-cell maturation in the thymus resulting in cells that recognize foreign antigens, which directly ties into the problem.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell can't recognize an antigen after mutation, it'll get rejected.",
    "rollout": " For example, if a T-cell can't recognize an antigen after mutation, it'll get rejected. So B would be the best answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell can't recognize an antigen after mutation, it'll get rejected. So B would be the best answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So B seems like the best answer because it directly ties mutation and recombination to T-cell maturation and foreign antigen recognition.",
    "rollout": " So B seems like the best answer because it directly ties mutation and recombination to T-cell maturation and foreign antigen recognition.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So B seems like the best answer because it directly ties mutation and recombination to T-cell maturation and foreign antigen recognition.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells aren't able to recognize foreign antigens, they won't attack the graft, causing rejection.",
    "rollout": " For example, if T-cells aren't able to recognize foreign antigens, they won't attack the graft, causing rejection. So combining mutation with recombination would mean that T-cells have altered receptors, making them less effective at attacking foreign materials. Therefore, B seems to be the best answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells aren't able to recognize foreign antigens, they won't attack the graft, causing rejection. So combining mutation with recombination would mean that T-cells have altered receptors, making them less effective at attacking foreign materials. Therefore, B seems to be the best answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So B fits best.",
    "rollout": " So B fits best.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So B fits best.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells aren't good at recognizing foreign antigens, they won't attack the foreign material, causing rejection.",
    "rollout": " For example, if T-cells aren't good at recognizing foreign antigens, they won't attack the foreign material, causing rejection. So B seems to fit best as it directly links mutation and recombination to T-cell maturation and antigen recognition.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells aren't good at recognizing foreign antigens, they won't attack the foreign material, causing rejection. So B seems to fit best as it directly links mutation and recombination to T-cell maturation and antigen recognition.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells aren't able to recognize antigens (like B), they won't attack the foreign material, causing rejection.",
    "rollout": " For example, if T-cells aren't able to recognize antigens (like B), they won't attack the foreign material, causing rejection. So B seems to cover that.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells aren't able to recognize antigens (like B), they won't attack the foreign material, causing rejection. So B seems to cover that.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So the main point here is that during T-cell maturation, mutations cause T-cells to recognize foreign antigens, which leads to rejection.",
    "rollout": " So the main point here is that during T-cell maturation, mutations cause T-cells to recognize foreign antigens, which leads to rejection. Therefore, the correct answer should be option B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So the main point here is that during T-cell maturation, mutations cause T-cells to recognize foreign antigens, which leads to rejection. Therefore, the correct answer should be option B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell can't recognize foreign antigens (like in B option), it would be rejected.",
    "rollout": " For example, if a T-cell can't recognize foreign antigens (like in B option), it would be rejected. Similarly, if there's a mutation causing recombination issues, the T-cell might misclassify antigens, leading to rejection. So putting it together, the answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell can't recognize foreign antigens (like in B option), it would be rejected. Similarly, if there's a mutation causing recombination issues, the T-cell might misclassify antigens, leading to rejection. So putting it together, the answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell doesn't recognize an antigen after mutation, it would be rejected.",
    "rollout": " For example, if a T-cell doesn't recognize an antigen after mutation, it would be rejected. So the key point here is whether mutation leads to better or worse recognition. Since the goal is rejection, mutation should impair T-cell recognition. Therefore, B seems to directly address that scenario.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell doesn't recognize an antigen after mutation, it would be rejected. So the key point here is whether mutation leads to better or worse recognition. Since the goal is rejection, mutation should impair T-cell recognition. Therefore, B seems to directly address that scenario.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell has mutations, it might not correctly recognize foreign antigens, causing it to be targeted instead of the original cell.",
    "rollout": " For example, if a T-cell has mutations, it might not correctly recognize foreign antigens, causing it to be targeted instead of the original cell. This leads to the body rejecting the graft. So among these options, B seems the best fit. It directly ties mutation during T-cell maturation to recognizing foreign antigens and rejecting the graft.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell has mutations, it might not correctly recognize foreign antigens, causing it to be targeted instead of the original cell. This leads to the body rejecting the graft. So among these options, B seems the best fit. It directly ties mutation during T-cell maturation to recognizing foreign antigens and rejecting the graft.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell doesn't recognize an antigen, it won't attack the graft, causing rejection.",
    "rollout": " For example, if a T-cell doesn't recognize an antigen, it won't attack the graft, causing rejection. So options B, C, D, E, F, G, H, J seem to tie into the mechanisms of how mutation impacts T-cell function. However, the original answer provided was B, but I need to verify why. The question asks how mutation and recombination contribute to tissue rejection. So B suggests that during T-cell maturation, mutations cause T-cells to recognize foreign antigens, leading to rejection. That makes sense because without proper antigen recognition, the T-cells can't target the foreign material, thus rejecting the graft. Therefore, the best answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell doesn't recognize an antigen, it won't attack the graft, causing rejection. So options B, C, D, E, F, G, H, J seem to tie into the mechanisms of how mutation impacts T-cell function. However, the original answer provided was B, but I need to verify why. The question asks how mutation and recombination contribute to tissue rejection. So B suggests that during T-cell maturation, mutations cause T-cells to recognize foreign antigens, leading to rejection. That makes sense because without proper antigen recognition, the T-cells can't target the foreign material, thus rejecting the graft. Therefore, the best answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So the key point is how mutations affect T-cells' ability to recognize foreign antigens.",
    "rollout": " So the key point is how mutations affect T-cells' ability to recognize foreign antigens. Therefore, option B fits best.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So the key point is how mutations affect T-cells' ability to recognize foreign antigens. Therefore, option B fits best.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell mutates and doesn't recognize foreign antigens, it would be targeted and thus rejected.",
    "rollout": " For example, if a T-cell mutates and doesn't recognize foreign antigens, it would be targeted and thus rejected. So B seems solid. The other options either talk about unrelated processes or incorrect mechanisms. Therefore, the best answer should be B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell mutates and doesn't recognize foreign antigens, it would be targeted and thus rejected. So B seems solid. The other options either talk about unrelated processes or incorrect mechanisms. Therefore, the best answer should be B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell doesn't recognize an antigen correctly, it will be targeted by the host's immune system, causing reactivation elsewhere, thus rejecting the graft.",
    "rollout": " For example, if a T-cell doesn't recognize an antigen correctly, it will be targeted by the host's immune system, causing reactivation elsewhere, thus rejecting the graft. So putting it all together, option B seems to directly address how mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell doesn't recognize an antigen correctly, it will be targeted by the host's immune system, causing reactivation elsewhere, thus rejecting the graft. So putting it all together, option B seems to directly address how mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell can't recognize an antigen, it won't attack it, causing rejection.",
    "rollout": " For example, if a T-cell can't recognize an antigen, it won't attack it, causing rejection. So combining mutation and recombination would enhance this resistance. Therefore, option B seems to be the best answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell can't recognize an antigen, it won't attack it, causing rejection. So combining mutation and recombination would enhance this resistance. Therefore, option B seems to be the best answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So focusing on B as the main answer makes sense.",
    "rollout": " So focusing on B as the main answer makes sense.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So focusing on B as the main answer makes sense.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells aren't recognizing foreign antigens well due to mutations, they won't stick to the foreign material, causing rejection.",
    "rollout": " For example, if T-cells aren't recognizing foreign antigens well due to mutations, they won't stick to the foreign material, causing rejection. So B seems to directly address this mechanism involving T-cell maturation and foreign recognition.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells aren't recognizing foreign antigens well due to mutations, they won't stick to the foreign material, causing rejection. So B seems to directly address this mechanism involving T-cell maturation and foreign recognition.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells aren't good at recognizing foreign antigens, they won't attack the graft, causing rejection.",
    "rollout": " For example, if T-cells aren't good at recognizing foreign antigens, they won't attack the graft, causing rejection. So B seems to directly address the mechanism of T-cell maturation leading to rejection. The rest might be talking about specific outcomes but aren't as central to the cause of rejection as B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells aren't good at recognizing foreign antigens, they won't attack the graft, causing rejection. So B seems to directly address the mechanism of T-cell maturation leading to rejection. The rest might be talking about specific outcomes but aren't as central to the cause of rejection as B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "- Option B specifically mentions T-cell maturation resulting in cells that recognize foreign antigens, which directly ties into graft rejection through T-cell activity.",
    "rollout": " - Option B specifically mentions T-cell maturation resulting in cells that recognize foreign antigens, which directly ties into graft rejection through T-cell activity. So putting it all together, option B is the best answer.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. - Option B specifically mentions T-cell maturation resulting in cells that recognize foreign antigens, which directly ties into graft rejection through T-cell activity. So putting it all together, option B is the best answer.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "So B seems to be the best answer because it directly links mutation and recombination to T-cell maturation and foreign antigen recognition, which leads to rejection.",
    "rollout": " So B seems to be the best answer because it directly links mutation and recombination to T-cell maturation and foreign antigen recognition, which leads to rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. So B seems to be the best answer because it directly links mutation and recombination to T-cell maturation and foreign antigen recognition, which leads to rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell can't recognize an antigen, it won't attack it, causing rejection.",
    "rollout": " For example, if a T-cell can't recognize an antigen, it won't attack it, causing rejection. So these options are supporting the role of mutation and recombination in rejecting the graft. \n\nLooking back, the key here is that T-cells need to recognize foreign antigens to attack them. If mutation allows T-cells to better recognize them, they'll be targeted, leading to rejection. So among the options, B and others talk about T-cell maturation resulting in cells that recognize foreign antigens. Therefore, the correct answer should involve T-cells recognizing antigens, which is option B.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell can't recognize an antigen, it won't attack it, causing rejection. So these options are supporting the role of mutation and recombination in rejecting the graft. \n\nLooking back, the key here is that T-cells need to recognize foreign antigens to attack them. If mutation allows T-cells to better recognize them, they'll be targeted, leading to rejection. So among the options, B and others talk about T-cell maturation resulting in cells that recognize foreign antigens. Therefore, the correct answer should involve T-cells recognizing antigens, which is option B.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell doesn't recognize an antigen properly, it will be targeted by the body, causing rejection.",
    "rollout": " For example, if a T-cell doesn't recognize an antigen properly, it will be targeted by the body, causing rejection. So the key here is that mutation and recombination enhance T-cell function, making them more effective at attacking foreign materials, thus aiding in rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell doesn't recognize an antigen properly, it will be targeted by the body, causing rejection. So the key here is that mutation and recombination enhance T-cell function, making them more effective at attacking foreign materials, thus aiding in rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if a T-cell has mutations, it might not recognize foreign antigens as well, increasing the risk of rejection.",
    "rollout": " For example, if a T-cell has mutations, it might not recognize foreign antigens as well, increasing the risk of rejection. So, considering these, option B fits best.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if a T-cell has mutations, it might not recognize foreign antigens as well, increasing the risk of rejection. So, considering these, option B fits best.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells aren't recognizing foreign antigens (like B), they won't attack the graft, causing rejection.",
    "rollout": " For example, if T-cells aren't recognizing foreign antigens (like B), they won't attack the graft, causing rejection. So these options together reinforce the idea that mutation and recombination specifically target T-cells' ability to recognize foreign materials, which is key to tissue rejection.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells aren't recognizing foreign antigens (like B), they won't attack the graft, causing rejection. So these options together reinforce the idea that mutation and recombination specifically target T-cells' ability to recognize foreign materials, which is key to tissue rejection.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  },
  {
    "chunk_removed": "So putting it together, the key point is that mutations during T-cell maturation allow these cells to recognize foreign antigens, which then leads to rejection of the graft.",
    "prefix_without_chunk": "Okay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection.",
    "chunk_resampled": "For example, if T-cells aren't recognizing foreign antigens correctly, they'd be targeted by the immune system, causing rejection.",
    "rollout": " For example, if T-cells aren't recognizing foreign antigens correctly, they'd be targeted by the immune system, causing rejection. So option B seems to cover that scenario.\n</think>\nThe correct answer is B",
    "full_cot": "<|im_start|>user\nAnswer this question step by step with only a single letter. Problem: How can mutation and recombination contribute to the process of tissue graft rejection?\n\nA. Mutation and recombination only occur in B-cells, not affecting T-cell mediated graft rejection.\n\nB. Mutation and recombination during T-cell maturation in the thymus result in cells that recognize foreign antigens, contributing to tissue graft rejection.\n\nC. Mutation and recombination prevent T-cells from recognizing foreign antigens.\n\nD. Mutation and recombination are involved in repairing damaged T-cells, which does not influence graft rejection.\n\nE. Mutation and recombination result in all cells recognizing their own antigens.\n\nF. Mutation and recombination reduce the immune response to foreign antigens.\n\nG. Mutation and recombination increase the chance of graft acceptance by enhancing immune tolerance.\n\nH. Mutation and recombination generate T-cells that cannot differentiate between self and non-self antigens.\n\nI. Mutation and recombination create identical T-cell receptors, reducing variability in immune response.\n\nJ. Mutation and recombination lead to the deletion of T-cells that can respond to foreign antigens.\n\nAnswer with only a single letter. Answer:<|im_end|>\n<|im_start|>assistant\n<think>\nOkay, so I'm trying to figure out how mutation and recombination contribute to tissue graft rejection. Let me break it down. First, I know that when a patient gets a new organ like a heart or liver, their body tries to grow a graft. If the donor's immune system doesn't recognize the foreign material, the body might reject the graft. That makes sense because if the immune system can't attack it, the body goes for other options, leading to rejection. Now, the question is about mutation and recombination. I remember that recombination involves mixing genetic material from different sources. So if there's mutation, maybe it changes some parts of the DNA, making the cells more likely to recognize foreign antigens. Looking at the options: - Option A says mutation and recombination don't affect B-cells. But wait, I think B-cells do play a role in fighting infections, including foreign ones. So probably A isn't right. - Option B talks about T-cell maturation. T-cells mature in the thymus, and mutations could make them better at recognizing antigens. When they recognize foreign ones, they get rejected. This seems relevant because T-cells help target the foreign material effectively, so B sounds correct. - Options C, D, E, F, G, H, J, etc., deal with things like T-cell recognition, repair, and immune responses. They mention processes like repair (D), creating identical receptors (I), deleting T-cells (J). These points support the idea that mutation affects T-cell function, leading to rejection. For example, if T-cells aren't recognizing foreign antigens correctly, they'd be targeted by the immune system, causing rejection. So option B seems to cover that scenario.\n</think>\nThe correct answer is B",
    "answer": "B",
    "is_correct": true
  }
]